Infectious Diseases
Guidance for Practicing Primary Care
Guideline: Diagnosis and treatment of adults with community-acquired pneumonia
The practice guideline was jointly written by an ad hoc committee of the American Thoracic Society and Infectious Diseases Society of America.
From the Journals
Two national analyses confirm safety of 9vHPV vaccine
Among 28 million doses delivered since 2015, 7,244 adverse events were reported – an event rate of 1 per 7 million vaccinations.
Conference Coverage
Hepatitis B debrief: Key themes that emerged at AASLD
BOSTON – Hot topics included HBV natural history, novel therapies, and prevention.
Conference Coverage
HVPG predicts clinical benefit after sustained virologic response
BOSTON – This provides, for the first time, firm evidence that HVPG can be taken as a surrogate endpoint for studies...
From the Journals
Free HIV self-tests for at-risk groups can increase awareness, testing frequency
“HIV prevention programs might consider adding an HIV self-testing mail distribution component to their portfolio,” the investigators wrote.
Article
FDA approves cefiderocol for multidrug-resistant, complicated urinary tract infections
The approval is for patients with limited or no alternative treatment options and includes a warning of Fetroja’s higher all-cause mortality rate...
News
CDC releases update of 2013 Antibiotic Resistance Threats Report
The report includes the hopeful news that there were 42 new antibiotics in development as of June 2019.
Conference Coverage
Rifabutin-based triple therapy for H. pylori gets high marks
SAN ANTONIO – This is the first new Helicobacter pylori eradication agent to be approved by the Food and Drug Administration in 22 years...
Conference Coverage
Short-course DAA therapy may prevent hepatitis transmission in transplant patients
BOSTON – While curing infection post transplant works, prevention would be preferable, investigators say.
Conference Coverage
Even low-dose steroids increase DMARD infection risk
ATLANTA – “It should be something you are aware of,” said Dr. Michael George.
From the Journals
Hepatitis C vaccine alters viral trajectory, but fails in chronic infection protection
BOSTON – First-ever randomized study does suggest changes in peak HCV RNA and an HCV RNA change after infection.